Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:37 pm Purchase |
2025-04-14 | 13G | Coherus BioSciences, Inc. CHRS |
SATTERFIELD THOMAS A JR | 6,009,514 5.200% |
6,009,514 (New Position) |
Filing History |
| 2025-04-16 5:36 pm Purchase |
2025-03-31 | 13G | Curis, Inc. CRIS |
SATTERFIELD THOMAS A JR | 1,035,762 9.900% |
245,330 (+31.04%) |
Filing History |
| 2025-02-18 4:15 pm Sale |
2025-02-13 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 0 0.000% |
-232,161 (Position Closed) |
Filing History |
| 2025-02-12 08:02 am Sale |
2024-12-31 | 13G | OS Therapies Incorporated OSTX |
SATTERFIELD THOMAS A JR | 1,267,465 5.900% |
-27,524 (-2.13%) |
Filing History |
| 2025-02-12 08:02 am Purchase |
2024-12-31 | 13G | inTEST Corporation INTT |
SATTERFIELD THOMAS A JR | 805,000 6.500% |
135,000 (+20.15%) |
Filing History |
| 2025-02-12 08:01 am Purchase |
2024-12-31 | 13G | Ark Restaurants Corp. ARKR |
SATTERFIELD THOMAS A JR | 574,251 15.900% |
38,694 (+7.23%) |
Filing History |
| 2025-02-12 08:00 am Purchase |
2024-12-31 | 13G | Scientific Industries, Inc. SCND |
SATTERFIELD THOMAS A JR | 1,138,055 9.900% |
192,430 (+20.35%) |
Filing History |
| 2025-02-12 08:00 am Purchase |
2024-12-31 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 232,161 6.700% |
56,117 (+31.88%) |
Filing History |
| 2025-02-12 08:00 am Purchase |
2024-12-31 | 13G | Curis, Inc. CRIS |
SATTERFIELD THOMAS A JR | 790,432 9.100% |
100,000 (+14.48%) |
Filing History |
| 2025-02-12 08:00 am Purchase |
2024-12-31 | 13G | BioCardia, Inc. BCDA |
SATTERFIELD THOMAS A JR | 388,147 8.200% |
388,147 (New Position) |
Filing History |
| 2025-01-17 4:05 pm Purchase |
2025-01-13 | 13G | Cytosorbents Corporation CTSO |
SATTERFIELD THOMAS A JR | 3,998,867 6.560% |
3,998,867 (New Position) |
Filing History |
| 2024-11-01 4:35 pm Purchase |
2024-10-30 | 13G | Curis, Inc. CRIS |
SATTERFIELD THOMAS A JR | 690,432 8.050% |
690,432 (New Position) |
Filing History |
| 2024-09-24 07:00 am Purchase |
2024-09-18 | 13G | inTEST Corporation INTT |
SATTERFIELD THOMAS A JR | 670,000 5.350% |
630,539 (+1597.88%) |
Filing History |
| 2024-08-28 4:30 pm Purchase |
2024-08-02 | 13G | OS Therapies Incorporated OSTX |
SATTERFIELD THOMAS A JR | 1,294,989 6.200% |
1,294,989 (New Position) |
Filing History |
| 2024-06-03 4:10 pm Purchase |
2024-05-30 | 13G | Edesa Biotech, Inc. EDSA |
SATTERFIELD THOMAS A JR | 176,044 5.470% |
176,044 (New Position) |
Filing History |
| 2024-02-14 5:06 pm Purchase |
2023-12-31 | 13G | BioCardia, Inc. BCDA |
SATTERFIELD THOMAS A JR | 113,400 7.870% |
37,426 (+49.26%) |
Filing History |
| 2024-02-14 5:05 pm Purchase |
2023-12-31 | 13G | Scientific Industries, Inc. SCND |
SATTERFIELD THOMAS A JR | 945,625 9.020% |
348,670 (+58.41%) |
Filing History |
| 2024-02-14 5:04 pm Purchase |
2023-12-31 | 13G | Safeguard Scientifics, Inc. SFE |
SATTERFIELD THOMAS A JR | 2,089,726 12.610% |
230,445 (+12.39%) |
Filing History |
| 2024-02-14 5:02 pm Sale |
2023-12-31 | 13G | Ark Restaurants Corp. ARKR |
SATTERFIELD THOMAS A JR | 535,557 14.860% |
-15,000 (-2.72%) |
Filing History |
| 2024-02-14 4:19 pm Purchase |
2023-12-31 | 13G | Alico, Inc. ALCO |
SATTERFIELD THOMAS A JR | 573,410 7.520% |
53,600 (+10.31%) |
Filing History |